Elicera Therapeutics publishes the annual report for 2022
Elicera Therapeutics publishes the annual report for 2022 Gothenburg, April 17, 2023 – Elicera Therapeutics AB (publ) (“Elicera”), a clinical stage cell and gene therapy company developing next-generation therapies based on oncolytic viruses and CAR T-cells armed with bystander immune activating properties, using the company’s proprietary and commercially available platform iTANK, publishes the annual report for 2022. Elicera Therapeutics annual report is now available at the webpage https://www.elicera.com. The Annual General Meeting will be held on May 16th at 3:00